Zhou Quan - Net Worth and Insider Trading

Zhou Quan Net Worth

The estimated net worth of Zhou Quan is at least $871 Million dollars as of 2024-12-15. Zhou Quan is the 2201 Interest of corporation controlled by you of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd and owns about 4,642,191 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) stock worth over $871 Million. Details can be seen in Zhou Quan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhou Quan has not made any transactions after 2023-07-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Zhou Quan

Zhou Quan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhou Quan owns 1 companies in total, including Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) .

Click here to see the complete history of Zhou Quan’s form 4 insider trades.

Insider Ownership Summary of Zhou Quan

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06990	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	2023-07-11	2201 Interest of corporation controlled by you

Zhou Quan Latest Holdings Summary

Zhou Quan currently owns a total of 1 stock. Zhou Quan owns 4,642,191 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) as of July 11, 2023, with a value of $871 Million.

Latest Holdings of Zhou Quan

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06990	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	2023-07-11	4,642,191	187.60	870,875,032

Holding Weightings of Zhou Quan

Zhou Quan Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhou Quan has made a total of 1 transactions in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is the sale of 4,642,191 shares on July 11, 2023, which brought Zhou Quan around $0.

Insider Trading History of Zhou Quan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhou Quan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zhou Quan Ownership Network

Ownership Network List of Zhou Quan

No Data

Ownership Network Relation of Zhou Quan

Zhou Quan Owned Company Details

What does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd do?

Who are the key executives at Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

Zhou Quan is the 2201 Interest of corporation controlled by you of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd. Other key executives at Sichuan Kelun-Biotech Biopharmaceutical Co Ltd include 2201 Interest of corporation controlled by you LIU Gexin , 2201 Interest of corporation controlled by you si chuan ke lun yao ye gu fen you xian gong si , and 2201 Interest of corporation controlled by you cheng du ke lun jing chuan ke ji you xian gong si .

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) Insider Trades Summary

Over the past 18 months, Zhou Quan made 1 insider transaction in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) with a net sale of 0. Other recent insider transactions involving Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) include a net purchase of 785,000 shares made by si chuan ke lun yao ye gu fen you xian gong si , a net purchase of 785,000 shares made by LIU Gexin , and a net sale of 97,305 shares made by Wellington Management Group LLP .

In summary, during the past 3 months, insiders sold 0 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 171,705 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) were sold and 1,644,400 shares were bought by its insiders, resulting in a net purchase of 1,472,695 shares.

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Insider Transactions

No Available Data

Zhou Quan Mailing Address

Above is the net worth, insider trading, and ownership report for Zhou Quan. Currently GuruFocus does not have mailing address information for Zhou Quan.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.